Abstract. Commercial enzyme-linked immunosorbent assays (ELISAs) for detection of serum antibodies to bovine viral diarrhea virus (BVDV), parainfluenza-3 virus (PI3V), respiratory syncytial virus (RSV), and infectious bovine rhinotracheitis virus (IBRV) were standardized to give a quantitative result when testing was performed at a single optimum dilution. For each test, serum samples were titrated and their end point titers calculated by an algebraic method directly from a plot of each titration series and also from a regression line fitted to this plot. The corrected optical density (COD) of each sample when tested at dilutions of 1/25, 1/50, and 1/100 was expressed as a percentage of the COD of a positive reference serum included on each plate, this value was the sample/positive (S/P) ratio. For each test, the linear relationship between the S/P ratio obtained at a dilution of 1/25, 1/50, and 1/100 and the end point titer calculated by each method was determined. In each case, the best linear relationship existed when samples were tested at a dilution of 1/100 (r = 0.973 for BVDV, 0.962 for PI3V, 0.961 for RSV, 0.947 for IBRV). From the equation of these lines, an increase in the S/P ratio between acute and convalescent serum samples of 31%, 23%, 21%, and 35% would correspond to a 4-fold rise in ELISA titer to BVDV, PI3V, RSV, and IBRV, respectively. ELISA titers calculated from S/P ratios at 1/100 were significantly related to virus neutralization titers to BVDV, RSV, and IBRV and to intraassay and interassay variation. Intraassay reproducibility ranged from 3.5% to 22.3% (coefficient of variation), with a median value of 9.5%. Interassay reproducibility was lower, ranging from 6.0% to 50.6%, with a median of 17.4%.
The etiology of bovine respiratory disease is complex, involving viral, bacterial and mycoplasmal agents. Of the viral agents, respiratory syncytial virus (RSV), parainfluenza-3 virus (PI3V), and infectious bovine rhinotracheitis virus (IBRV) are recognized as primary respiratory pathogens. 5, 28, 30 Evidence implicating bovine viral diarrhea virus (BVDV) as a cause of respiratory disease remains equivocal. Although this virus has been recovered from the lungs of pneumonic animals, 22 such isolates have induced only mild pulmonary lesions following experimental inoculation. 21 Nevertheless, the significant immunosuppression associated with acute BVDV infection 4, 23, 24, 31 is now accepted to have a potentiating effect on the severity and extent of lung lesions resulting from infection with recognized viral and bacterial respiratory pathogens. 20, 22 Serologic diagnosis of infection with these viruses may be performed by demonstrating a significant (4-fold) rise in titer in paired acute and convalescent samples. A number of different methods have been used to titrate sera for antibody to these viruses, including virus neutralization (VN), complement fixation (CF), hemagglutination inhibition (HI), and indirect immunofluorescent antibody testing. 1, 7, 10 ELISAs have also been used to perform end point titrations, and antibody titers to a number of viruses correlate well with those obtained by VN, CF, and HI. 8, 11, 12, [15] [16] [17] 32 Although testing by ELISA is recognized as being more rapid and less labor intensive than these other methodologies, the testing of serial dilutions limits the number of samples that can be tested on each plate to as few as 6 (i.e., 3 pairs) when control antigen wells are included for each dilution.
Single dilution quantitative assays, based on the linear relationship between ELISA values at a single op-timum dilution and end point titers obtained by VN or ELISA, have been reported for several viruses.
2,3,6, 14 The application of this type of single dilution assay to the testing of paired sera for seroconversion to several different viruses offers considerable scope for savings and makes the testing of large numbers of samples more practical. We therefore decided to investigate the suitability of single dilution quantitative ELISAs for the testing of paired serum samples to detect seroconversion to IBRV, RSV, PI3V, and BVDV. In this paper, we describe the initial standardization of these tests, which first involved determining the dilution for each test at which the linear relationship between the ELISA value at that dilution and the ELISA end point titer was strongest and then determined the equation defining this relationship for each test. From these equations, we calculated the increase in ELISA value that corresponded to a 4-fold rise in ELISA titer.
Materials and methods

Bovine sera
One hundred forty-five serum samples collected from calves with respiratory disease were used. A further 10 sera were taken from animals experimentally infected. All serum samples contained specific antibodies to 1 or more respiratory viruses (IBRV, RSV, PI3V, BVDV). Sera were stored at -20 C prior to use. Those used in VN or HI testing were first heat inactivated at 56 C for 30 min.
ELISA kits
Qualitative solid-phase antibody-capture ELISA kits to detect RSV-, IBRV-, PI3V-, and BVDV-specific IgG were obtained from a single commercial source.
a Tests were performed according to the manufacturers' instructions. Serum samples at the appropriate dilution(s) in phosphate-buffered saline (PBS)-Tween buffer (0.01 M PBS containing 0.05% Tween 20) were added to each of 2 wells, 1 coated with viral antigen and the other with control antigen, to a final volume of 100 µl. Positive and negative reference sera were included on each plate at a dilution of 1/25. Each plate was then shaken, sealed, and incubated for 1 hr at 37 C and then washed 3 times in PBS-Tween buffer. After the third wash, each plate was tapped dry, and 100 µl of horseradish peroxidase-conjugated anti-bovine IgG was added. Each plate was then incubated for 1 hr at 37 C and washed as above. After washing, 100 µl of substrate solution (3,3',5,5'-tetramethylbenzidine and hydrogen peroxide) was added to each well, and each plate was incubated at room temperature for 10 min. The reaction was then stopped by adding 50 µl of 2 M H 2 SO 4 per well. After shaking, the absorbance (optical density [OD]) of each well at 450 nm was measured on a microplate plate reader.
b The corrected optical density (COD) value of each sample and reference serum was obtained by subtraction of the OD value of each control antigen-coated well from that of the parallel viral antigen-coated well. Based on values supplied by the manufacturer, samples with a COD value >0.2 were regarded as positive for antibodies to PI3V, IBRV, and RSV and those with values >0.25 were regarded as positive for BVDV.
Determination of ELISA titers
For each test, individual sera that gave a range of positive COD values from 0.3 to 2.45 when initially tested were selected. These sera were further tested using serial 2-fold dilutions beginning at 1/25. Thirteen samples were titrated for RSV, 14 for BVDV and PI3V, and 15 for IBRV. For each sample, a plot of OD value against the reciprocal of the dilution (1og 2 ) was then used to calculate the intercept of the line with the specified cutoff value of each test, this value being taken as the ELISA end point titer. First, the intercept of each line as plotted was determined algebraically by calculating the equation of the line joining the 2 points above and below the cutoff value in each titration series and solving this for the cutoff value (titer x line). Second, a regression line was fitted to the linear portion of each graph (titer x regression), and the equation of this line was solved for the cutoff value. In all cases, this linear portion included the 2 data points used in the titer x line method. Positive and negative reference sera were included at 1/25.
Determination of correlation between ELISA titer and single dilution test value
Having determined the ELISA end point titer of a number of samples for each test by 2 different methods, the relationship between these titers and the sample/positive (S/P) ratio of each of these samples at dilutions of 1/25, 1/50, and 1/100 was examined. The S/P ratio was calculated according to the formula S/P ratio = 100 x COD sample /COD positive reference serum . For each dilution tested (1/25, 1/50, 1/100) on each of the ELISAs, the ELISA titer as determined by regression was plotted against the S/P ratio, and a regression line was fitted to the plot. This procedure was then repeated substituting ELISA titers calculated from the actual line. The goodness of fit of each of the plots was measured by calculating the correlation coefficient of this regression line. The equation of each regression line was calculated and expressed in the form y = mx + c, where y = S/P ratio, m = slope of the line, x = ELISA titer(log 2 ), and c = the intercept value with the y-axis. The test dilution that gave the best straight line fit was then determined for each test. Using the equation of this standard curve for each test, the increase in S/P ratio value equivalent to a 4-fold rise in ELISA titer was calculated.
Cells and virus
Vero and fetal bovine lung (FBL) cells used in the VN tests were grown in minimal essential medium (MEM) supplemented with 10% irradiated fetal calf serum containing penicillin and streptomycin at concentrations of 100 IU/ml and 100 µg/ml, respectively. RSV L13 SPA, a vaccinal strain of RSVc, had a titer of 10 3.9 TCID 50 /50 µl in Vero cells. IBRV WPM1 strain Colorado was at third passage and had a titer of 10 5.7 TCID 50 /50 µl in FBL cells. BVDV WPE4 strain NADL was at eighth passage and had a titer of 10 3.0 TCID 50 /50 µl in FBL cells. PI3V 125 C3 was a Northern Ireland field isolate at sixth passage in FBL and had a hemagglutination (HA) titer of 1/90 in 0.75% guinea pig erythrocytes.
Correlation between ELISA titers and VN/HI titers Testing was carried out to determine the VN titers to RSV of 30 different sera, to IBRV of 40 different sera, and to BVDV of 26 different sera. All of these samples had previously tested positive by ELISA and were selected to ensure that sera with a wide range of COD values were represented. Some sera were used for more than 1 test. Serial 2-fold dilutions of each serum from 2 2 to 2 13 were tested using standard procedures in microtiter plates using 50 µl volumes of virus, serum, and cells. Each dilution was tested in duplicate, and the geometric mean titer was calculated. Virus was added at 100 TCID 50 /well. Thirty different ELISA-positive sera were also tested to determine their HI titers to PI3V. Serum, cell, and virus controls were run in all tests.
RSV kit, 14 on the BVDV kit, and 15 on both the IBRV and PI3V kits. For each test, the plot that gave the best fit on the initial calibration, as defined by the dilution at which samples were tested and the method used to determine end points, was identified. The equation and correlation coefficient of the regression line fitted to this plot and the change in S/P ratio representing a 4-fold rise in ELISA titer were calculated and compared with those produced by the initial standardization.
RSV. VN testing was performed using Vero cells based on a protocol described previously 18 with the end point being determined after 72 hr by indirect immunoperoxidase staining using a monoclonal antibody-based detection system. The end point was taken as the highest serum dilution showing 100% neutralization. Monoclonal antibody 19 is specific for the fusion protein 29 of RSV, and binding was detected by the labeled streptavidin-biotin method using commercial reagents.
d IBRV. VN testing was performed in FBL according to standard methods. 9 Serum and virus were incubated for 1 hr at 37 C prior to addition of cells. Tests were read after 5 days according to the presence or absence of virus-induced cytopathic effect (CPE) in wells.
BVDV. Testing was performed as for IBRV with the absence of CPE in test wells indicating the presence of neutralizing antibodies.
PI3V. HI testing was carried out as previously described' using 4 HA units of virus and 0.75% guinea pig erythrocytes in V-well microtiter plates. Samples were tested in serial 2-fold dilutions from 2 1 to 2 11 , with each dilution series tested in a single lane. Each sample was also tested on the related ELISA kit at the optimum dilution as determined above, and the S/P ratios were calculated at that dilution. The equation describing the relationship between S/P ratio and ELISA titer at that dilution was then used to calculate the ELISA titer of each sample. Regression of ELISA titer on VN or HI titer was then performed, and the correlation coefficient was calculated.
Reproducibility
For each of the 4 ELISA tests, 3 samples giving a low S/P ratio (≤ 12%), medium S/P ratio (12-40%), and high S/P ratio (40-88%) at a dilution of 1/100 were identified. The intraassay variability was determined by testing each of these 3 samples 5 times on a single plate, with well allocations assigned randomly. To measure interassay variability, these 3 samples were tested on 5 different occasions by the same operator. For each of these sets of data, the mean, the standard deviation, and coefficient of variation (%CV = 100 x standard deviation/mean) of the COD values and the corresponding S/P ratios were calculated. To examine the effect on the standard curve of changing the batch number of the kits, the standardization procedure was repeated on a second batch of each kit. Thirteen samples were re-analyzed on the
Data processing and statistical analysis
All data were processed using a commercial software package, e with linear regression analysis performed by the leastsquares method.
Results
Determination of ELISA titers. Plots of OD value against the reciprocal of the dilution factor (log,) for each ELISA were linear in nature until the OD value had fallen to below the cutoff value (data not shown). Below this, the plots tended to tail off toward 0. The OD values of some samples that were strongly positive at a dilution of 1/25 showed an initial plateau effect and did not begin to decrease until they had been diluted to 1/100 or 1/200. The regression lines fitted to the linear portions of these plots all had high coefficients of correlation (R = 0.935-0.998 in 56 plots), indicating a strong linear trend over the regions examined.
Determination of correlation between ELISA titer and S/P ratio. Plots of S/P ratio at each dilution against ELISA titer determined by the line method and by the regression method are shown in Figs. 1 and 2 , respectively. The results of the statistical analysis of each of the 24 plots are summarized in Table 1 . For RSV, PI3V, and IBRV, correlation between S/P ratio and ELISA titer was greatest at a dilution of 1/100 (r = 0.961, 0.965, and 0.947, respectively), indicating a strong linear relationship between ELISA titer and S/P ratio in all cases (P 0.001). For BVDV, the correlation coefficients at 1/50 and 1/100 were the same (r = 0.973, P 0.001).
The method of calculation of the ELISA titer had little impact on the correlation recorded at each dilution. The best correlation was achieved in 2 cases using ELISA titers calculated by regression and in 2 other cases using ELISA titers calculated by the line method.
The m and c values of the equations describing these lines at 1/100 and the increase in S/P value representing a 4-fold rise in ELISA titer are included in Table 2 . The increase in S/P ratios in paired samples indicative of a 4-fold rise in ELISA titer ranged from 21.0% (RSV) to 35.0% (IBRV).
Correlation between ELISA titers and VN/HI titers. The plots of ELISA titers against VN or HI titers and their regression lines for each of the 4 tests are shown positive samples. The results of the second standardization of each kit are included in Table 2 . There was close agreement between the results of the first and second calibration experiments, with little change in the value representing a 4-fold rise in ELISA titer.
Discussion
We have successfully adapted commercially available ELISA kits for quantitative estimation of antibodies to IBRV, RSV, PI3V, and BVDV and demonstrated that titers determined in this way are significantly related to those obtained by VN and HI. This type of test, based on a single dilution, is much more practical for diagnostic laboratories to perform than is end-point titration and will lend itself to the testing of acute and convalescent serum samples for evidence of seroconversion to multiple agents.
The titer line method was a modification of a pre- Table 2 . Details of regression lines that gave the best correlation between ELISA titers and S/P ratios for each virus test. Sample dilutions were 1/100. Goodness of fit was measured by the correlation coefficient (r). The slope (m) and intercept (c) with the y-axis of each line was determined, and from this equation the increase in S/P ratio equivalent to a 4-fold rise in ELISA titer was calculated. Comparable results from a second standardization experiment are given in parentheses.
viously described procedure 2,25 for determining ELISA end point titers, with the intercept values calculated from an algebraic formula rather than determined directly from the graph. The possibility existed that errors associated with the determination of the 2 OD values used in each calculation could subsequently negatively influence the goodness of fit of the linear relationship between ELISA titer and single dilution test value. For this reason, the regression method of determining ELISA titer was also used, where the median number of data points used to construct each regression line and calculate each titer was 6 (data not shown). The correlation coefficient (r) of these regression lines ranged from 0.935 to 0.998 (data not shown), indicating a strongly linear relationship in all cases.
In practice, neither method demonstrated a distinct advantage. Two of the tests (RSV, PI3V) produced the best fit based on titers generated using the regression method, and the other 2 gave the best fits using titers generated by the line method. Similar methods of data manipulation have previously given similar high coefficients of correlation. 27 When performing single dilution quantitative ELISAs, other researchers 2,3,6,11,14,28 have typically used dilutions in the range of 1/50-1/200, although a much higher dilution of 1/1,840 has also been used. 25 Over the range of dilutions we examined, the correlation between S/P ratio and ELISA titer generally increased with dilution, reflecting the fact that at low dilutions the S/P ratio of some strongly positive samples did not fall significantly until the samples had been serially diluted several times. This result is presumably due to the limiting effect of the concentration of capture antigen, of peroxidase-labeled antibody, or of both in the face of very high specific antibody concentration. Of the three dilutions we examined, the best correlation between S/P ratio and ELISA titer was obtained at 1/100 with RSV (r = 0.961), PI3V (r = 0.965), and IBRV (r = 0.947). For BVDV, the r value at 1/50 and 1/100 was the same (0.973, P 0.001 in all cases). From the equation of the regression lines fitted to these plots at 1/100, the percentage increase in S/P ratio of paired samples to indicate a 4-fold or greater increase in ELISA titer to BVDV, RSV, IBRV, and PI3V was calculated to be 31.0%, 21.0%, 35.0%, and 23.0%, respectively.
Two problems have been associated with this type of single dilution quantitative assay. 28 First, the time required to add samples individually to a plate can result in significant differences in OD value because of different incubation times. To minimize this effect, samples were initially diluted on a reservoir plate to either their final test dilution or to 10% of this figure. Samples were then rapidly transferred to the test plate using multichannel pipettes, where if necessary the final 10-fold dilution was effected by transferring 10 µl to 90 µl of PBS-Tween dilution buffer in each well of the ELISA plate. Second, it is necessary to construct a new standard curve each time any reagent batch is changed. By using commercial kits as our starting point, we have ensured that all reagents change at the same time, minimizing the frequency with which restandardization is required. The effect of changing to a new batch of kits was relatively small, with the difference in S/P ratio indicative of a 4-fold rise in ELISA titer changing from 31% to 35% for BVDV, from 21% to 20% for RSV, from 23% to 25% for IBRV, and from 30% to 31% for PI3V. A larger number of different batches must be examined to confirm the consistency of this finding.
When studying the correlation between S/P ratio of samples tested at a single dilution and their titer by VN or HI, all ELISA tests were performed at a dilution of 1/100. Typically, samples that gave the same titer by VN or HI showed a range of titers by ELISA, and the correlation coefficients of the regression lines fitted to these plots varied from a minimum of 0.657 for Table 3 . Reproducibility of results for each virus test kit. Three serum samples that respectively gave low, medium, and high absorbance values when tested at 1/100 were each tested 5 times at a dilution of 1/100 on the same plate to determine intraassay variation and 5 times on different days to measure interassay variation. Results are expressed as the coefficient of variation (% CV) of the sample/positive (S/P) ratio for each serum sample and the corrected optical density (COD) of each sample. in all cases). Both acute and convalescent sera were included in each test. Following natural and experimental infections, VN titers begin to rise before ELISA titers 13, 14, 27, 32 because the ELISA detects only IgG, the presence of low-affinity antibody, or both. Therefore, a higher correlation might have resulted had only convalescent sera been used.
Titers determined by ELISA have occasionally been up to 100-fold greater than VN or HI titers. 19, 25 We did not observe this increased sensitivity in our tests; ELISA titers were at best 3 times higher than those obtained in HI or VN tests (data not shown). The sensitivity of this type of ELISA is linearly related to the concentration of antigen used to coat the plate. 17 Therefore, an increase in the coating antigen concentration on the plates could result in higher ELISA titers.
Intraassay reproducibility of results was good, with a median %CV of 9.5%. With the exception of the medium-and high-positive PI3V samples, the interassay variation of the S/P ratios was greater than the intraassay variation (median = 17.4%), as has been previously reported for this type of test.
3
The S/P ratio has been used in preference to COD values in an attempt to minimize interassay variation. Although the median %CV for the interassay S/P ratio variation was slightly lower than that of the interassay COD variation ( 17.4% vs. 19.38%), the reproducibility of the S/P ratio was better than that of the COD value in only 7 of 12 cases. Furthermore, the largest interassay variation was associated with the S/P ratio of the low-positive IBRV sample, which had a %CV of 50.6%. This finding suggests that in some cases the use of the COD value of the positive reference sera in calculating S/P ratios exaggerates the interassay variation rather than helping to minimize it.
A linear relationship between single dilution ELISA value and end point ELISA titer has been described for BVDV 11 but was not applied to the detection of seroconversion. Single dilution quantitative ELISAs based on the linear relationship between ELISA value and end point VN titer have previously been applied to the detection of seroconversion to IBRV/.
6,14 To our knowledge, the linear relationships we describe between single dilution ELISA values and ELISA end point titers for RSV, PI3V, and IBRV have not been reported previously, and this is the first time that this linear relationship has been standardized in this way to detect seroconversion to these 4 viruses.
The use of the same dilution factor in all 4 tests and the initial preparation of samples as 10% dilutions on a reservoir plate from which they can be rapidly transferred to different microtiter plates will allow all 4 tests to be performed simultaneously by the same operator. Although our specific interest is in the application of single dilution testing to the detection of seroconversion to RSV, PI3V, IBRV, and BVDV, our results suggest that other antibody-detecting ELISAs could also be standardized in this way and applied either to determining the titer of single samples or to the demonstration of seroconversion in paired samples. Not all laboratories have access to the tissue culture facilities and other equipment needed to produce ELISA reagents. Our use of commercial kits as a starting point for this work indicates that this limitation need not be a barrier to such laboratories developing this type of test.
We have developed a rapid, reproducible, and costeffective quantitative assay, using commercially available ELISA kits, that should be readily applicable to the detection of seroconversion to BVDV, IBRV, RSV, and PI3V in acute and convalescent serum samples from outbreaks of bovine respiratory disease. We are currently using these protocols to examine paired sera submitted to the laboratory for evidence of seroconversion, and these results will be reported soon.
